SCHEMBL10713987

SCHEMBL10713987

CCC(C(=O)O)c1ccc(-c2ccccc2)c(N)c1

nearest known ligand 0.54

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 19/20 0.54
▸ AKR1C2 P52895 19/20 0.54
▸ AKR1C1 Q04828 3/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ AKR1B10 O60218 2/20 0.46
▸ AKR1C4 P17516 2/20 0.46
▸ HTR1A P08908 1/20 0.45
▸ ADRA1A P35348 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4201800 0.82 AKR1C3 (0.76) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL7384712 0.80 AKR1C3 (0.68) AKR1C3AKR1C2AKR1C1PTGS1AKR1C4
SCHEMBL7900941 0.79 AKR1C3 (0.51) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL5099274 0.78 ALDH1A1 (0.60) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL18290903 0.78 AKR1C3 (0.61) AKR1C3AKR1C2AKR1C1AKR1B10AKR1C4
Xenbucin SCHEMBL24134 0.77 PTGS2 (0.58) AKR1C3AKR1C2AKR1C1PTGS1HTR1A
SCHEMBL19202485 0.77 AKR1C3 (0.54) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL18290907 0.77 AKR1C3 (0.49) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL20553863 0.76 AKR1C3 (0.51) AKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL1556908 0.75 AKR1C3 (0.51) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9518050-B2 Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity ALMIRALL, S.A. (ES) 2016-12-13 — — US disclosed
US-4670566-A ANTIIFLAMMATORY AGENTS, ANTICOAGULANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-06-02 — — US disclosed
US-4440785-A Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation A. H. ROBINS COMPANY, INC. (US) 1984-04-03 — — US disclosed
Send feedback